TPST Tempest Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 13, 2026
$0,81
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$0,7452 haftanın en düşüğü
$12,2352 haftanın en yükseği
Piyasa Değeri (MRQ)
$13M
P/E
-0.1
Hisse Başına Kâr
$-6.33
rozetleriniz
52 Haftlık Aralık
$1–$12
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$7
P/E
-0.1
ROE
-319.3%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
TPST Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.81
Piyasa Değeri (MRQ)
$13M
P/E
-0.1
Hisse Başına Kâr
$-6.33
ROE
-319.3%
D/E Borç/Özsermaye
0.0
52 Haftlık Aralık
$1–$12
TPST Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 09 Nisan 2025 | 1-for-13 | Ters |
| 28 Haziran 2021 | 1-for-15 | Ters |
| 10 Aralık 2018 | 1-for-15 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-6.332020-12-31 → 2025-12-31
Serbest Nakit Akışı$-27M2018-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | TPST | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -0.15Y ort. ≈-9.0 | ≈-9.0 | · | · | |
| P/S (F/S) | 15.45Y ort. ≈1843.5 | ≈1843.5 | · | · | |
| F/D (MRQ) | -11.95Y ort. ≈19.3 | ≈19.3 | · | · | |
| EV / EBITDA | 0.15Y ort. ≈-15.5 | ≈-15.5 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -0.65Y ort. ≈-17.1 | ≈-17.1 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -0.65Y ort. ≈-17.2 | ≈-17.2 | · | · | |
| EV / Revenue (EV / Gelir) | -14.35Y ort. ≈1769.8 | ≈1769.8 | · | · | |
| EV / FCF | 0.15Y ort. ≈-16.4 | ≈-16.4 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 0.65Y ort. ≈19.2 | ≈19.2 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | TPST | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -89.9%5Y ort. ≈-70.0% | ≈-70.0% | -89.9% | Aynı seviyede | |
| ROE | -319.3%5Y ort. ≈-236.3% | ≈-236.3% | -165.1% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | TPST | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Debt / Equity (Borç / Öz Sermaye) | 0.05Y ort. ≈0.3 | ≈0.3 | · | · | |
| Cari Oran (MRQ) | 0.45Y ort. ≈3.8 | ≈3.8 | 3.7 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 2.35Y ort. ≈3.6 | ≈3.6 | 3.5 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-101.6%
Sonraki Rapor
Kas 03, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 10, 2026 | $-0.34 | $-0.31 | -11.1% |
| 31 Mart 2026 | May 14, 2026 | $-2.53 | $-0.29 | -785.9% |
| 31 Aralık 2025 | $-0.62 | $-0.63 | 2.0% | |
| 30 Eylül 2025 | $-0.79 | $-3.34 | 76.3% | |
| 30 Haziran 2025 | $-2.07 | $-2.66 | 22.1% | |
| 31 Mart 2025 | $-3.16 | $-3.36 | 5.9% | |
| 31 Aralık 2024 | $-4.03 | $-3.34 | -20.6% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | $295.0K | $653.0K | $277.0K | $0 | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $790.0K | $5M | $2M | $0 | |
| R&D Expense | · | · | · | · | · | · | · | · | $18M | $22M | $18M | $22M | |
| SG&A Expense | $14M | $14M | $12M | $12M | $10M | $5M | $18M | $9M | $6M | $49M | $52M | $26M | |
| Operating Expenses | · | · | · | · | · | · | · | · | $51M | $82M | $72M | $48M | |
| Operating Income | $-27M | $-42M | $-29M | $-35M | $-27M | $-19M | $-45M | $-27M | $-84M | $-81M | $-72M | $-48M | |
| Interest Expense | · | · | $1M | $2M | $1M | $0 | · | $134.0K | $288.0K | · | · | · | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $-126.0K | |
| Other Non-op | $520.0K | $1M | $1M | $549.0K | $-34.0K | $90.0K | · | · | $-36.0K | $-164.0K | $-20.0K | $122.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | $-51M | $-82M | $-73M | $-50M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $67.0K | $201.0K | $75.0K | $0 | |
| Net Income | $-26M | $-42M | $-29M | $-36M | $-28M | $-19M | $-45M | $-27M | $-85M | $-82M | $-73M | $-50M | |
| EPS (Basic) | $-6.33 | $-19.50 | $-1.91 | $-3.09 | $-7.47 | $-41.03 | · | · | · | · | · | · | |
| EPS (Diluted) | $-6.33 | $-19.50 | $-1.91 | $-3.09 | $-7.47 | $-41.03 | · | · | · | · | · | · | |
| Shares (Basic) | 4,149,733 | 2,146,276 | 15,416,203 | 11,548,907 | 3,790,303 | 468,161 | · | · | · | · | · | · | |
| Shares (Diluted) | 4,149,733 | 2,146,276 | 15,416,203 | 11,548,907 | 3,790,303 | 468,161 | · | · | · | · | · | · | |
| EBITDA | $-27M | · | $-29M | $-35M | · | · | $-45M | $-27M | $-49M | $-79M | $-71M | $-47M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $30M | $39M | $31M | $52M | $19M | $62M | $73M | $18M | $44M | $43M | $6M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $52M | $70M | $83M | $54M | |
| Prepaid Expense | $562.0K | $1M | $1M | $1M | $2M | $1M | $6M | $3M | $1M | $2M | $3M | $2M | |
| Other Current Assets | $355.0K | $535.0K | $96.0K | $263.0K | $553.0K | $59.0K | · | · | · | · | · | · | |
| Current Assets | $8M | $31M | $40M | $33M | $69M | $20M | $71M | $83M | $20M | $116M | $130M | $62M | |
| PP&E (Net) | $605.0K | $886.0K | $840.0K | $1M | $1M | $1M | · | · | $3M | $6M | $8M | $3M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | · | · | $7M | $9M | $11M | $5M | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $824.0K | $456.0K | · | · | $4M | $3M | $2M | $1M | |
| Other Non-current Assets | $517.0K | $485.0K | $448.0K | $429.0K | $111.0K | $51.0K | $507.0K | $213.0K | $74.0K | $23.0K | $0 | $130.0K | |
| Total Assets | $17M | $41M | $52M | $46M | $73M | $23M | $75M | $84M | $20M | $123M | $139M | $66M | |
| Accounts Payable | $1M | $2M | $845.0K | $1M | $991.0K | $1M | $1M | $2M | $1M | $2M | $3M | $3M | |
| Accrued Liabilities | $937.0K | $3M | $2M | $3M | $2M | $665.0K | $9M | $8M | $3M | $11M | $8M | $8M | |
| Short-term Debt | · | · | · | · | $0 | · | · | · | · | · | · | · | |
| Current Liabilities | $3M | $14M | $9M | $7M | $20M | $3M | $13M | $10M | $4M | $13M | $11M | $10M | |
| Capital Leases | $7M | $8M | $9M | $10M | $2M | $2M | $2M | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | $0 | $16.0K | $752.0K | $751.0K | $1M | $520.0K | $73.0K | |
| Total Liabilities | $10M | $22M | $25M | $28M | $37M | $5M | $15M | $11M | $5M | $14M | $12M | $10M | |
| Long-term Debt | · | $6M | $10M | $10M | · | $239.0K | $376.0K | $572.0K | · | · | · | · | |
| Total Debt | $0 | · | $11M | $10M | · | · | $376.0K | $383.0K | · | · | · | · | |
| Common Stock | $5.0K | $3.0K | $22.0K | $11.0K | $7.0K | $1.0K | $18.0K | $13.0K | $36.0K | $36.0K | $27.0K | $24.0K | |
| Paid-in Capital | $240M | $226M | $192M | $154M | $136M | $3M | $267M | $235M | $6M | $358M | $295M | $150M | |
| Retained Earnings | $-233M | $-207M | $-165M | $-136M | $-100M | $-72M | $-209M | $-164M | $-137M | $-250M | $-168M | $-95M | |
| AOCI | · | · | · | · | · | $452.0K | $165.0K | $148.0K | $8.0K | $-60.0K | $-170.0K | $-26.0K | |
| Stockholders' Equity | $7M | $19M | $27M | $18M | $36M | $-69M | $-50M | $71M | $-131M | $108M | $127M | $55M | |
| Liabilities + Equity | $17M | $41M | $52M | $46M | $73M | $23M | $75M | $84M | $20M | $123M | $139M | $66M | |
| Shares Outstanding | 4,927,161 | 3,382,432 | 22,045,255 | 10,518,539 | 6,910,324 | 527,265 | 18,266,545 | 13,357,999 | 246,347 | 35,641,505 | 27,296,747 | 24,084,637 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | $2M | $2M | $1M | $450.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | · | $7M | $9M | $19M | $12M | |
| Restructuring | · | · | · | · | · | · | · | · | $4M | $5M | $0 | $0 | |
| Other Non-cash | · | · | · | · | · | · | · | · | $-3M | $9M | $2M | $6M | |
| Operating Cash Flow | $-27M | $-33M | $-27M | $-31M | $-26M | $-19M | $-41M | $-24M | $-20M | $-62M | $-50M | $-31M | |
| CapEx | $0 | $435.0K | $170.0K | $562.0K | $135.0K | $50.0K | $397.0K | $36.0K | $4.0K | $3M | $5M | $3M | |
| Investing Cash Flow | $0 | $-435.0K | $-170.0K | $-562.0K | $-97.0K | $-6.0K | $4M | $2M | $458.0K | $8M | $-38M | $-33M | |
| Debt Issued | · | · | · | · | $15M | $0 | · | · | · | · | · | · | |
| Stock Issued | $6M | $29M | $36M | $9M | $33M | $0 | $27M | $0 | $0 | $54M | $124M | $52M | |
| Net Stock Activity | $6M | · | $36M | $9M | · | · | $27M | · | $0 | $54M | $124M | $52M | |
| Financing Cash Flow | $4M | $24M | $36M | $11M | $59M | $35M | $27M | $78M | $-4M | $54M | $125M | $52M | |
| Net Change in Cash | · | · | · | · | · | $-25M | $-10M | $56M | $-24M | · | · | · | |
| Taxes Paid | $0 | $0 | · | · | · | · | $0 | $4.0K | · | · | · | · | |
| Free Cash Flow | $-27M | · | $-28M | $-32M | · | · | $-42M | $-24M | $-46M | $-64M | $-56M | $-33M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -17154.6% | -12406.1% | -25992.4% | · | |
| Net Margin | · | · | · | · | · | · | · | · | -17279.7% | -12597.2% | -26432.9% | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | -17257.0% | -12566.5% | -26405.8% | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -16595.2% | -12063.4% | -25528.2% | · | |
| ROA | -89.9% | · | -60.4% | -59.9% | · | · | -56.0% | -52.3% | -52.2% | -63.0% | -71.7% | -87.6% | |
| ROE | -319.3% | · | -230.6% | -159.1% | · | · | -68.8% | 91.0% | -59.1% | -70.0% | -80.4% | -102.1% | |
| ROIC | · | · | · | · | · | · | · | · | -78.8% | -75.0% | -56.8% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | · | 4.3 | 4.5 | · | · | 5.7 | 8.5 | 8.8 | 8.8 | 11.6 | 6.1 | |
| Quick Ratio | 2.3 | · | 4.2 | 4.3 | · | · | 5.0 | 7.5 | 8.6 | 8.7 | 11.3 | 5.9 | |
| Debt / Equity | 0.0 | · | 0.4 | 0.6 | · | · | 0.0 | 0.0 | · | · | · | · | |
| LT Debt / Equity | · | · | 0.2 | 0.6 | · | · | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | · | · | -20.1 | -21.4 | · | · | · | -200.6 | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.35 | · | $1.21 | $1.72 | · | · | $3.21 | $5.31 | $1.80 | $3.04 | $4.65 | $2.30 | |
| Cash Flow / Share | $-6.46 | · | $-1.77 | $-2.69 | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.56 | · | $1.78 | $2.97 | · | · | $3.42 | $5.49 | $0.44 | $1.23 | $1.58 | $0.27 | |
| Dividend / Share | · | · | · | · | · | $0.00 | $0.00 | $0.00 | · | · | · | · | |
| EPS (TTM) | $-6.33 | $-19.50 | $-1.91 | $-3.09 | $-7.47 | $-41.03 | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $259.0K | $259.0K | $259.0K | $259.0K | $259.0K | $259.0K | $259.0K | $259.0K | $295.0K | $653.0K | $277.0K | $0 | |
| Net Income TTM | $-26M | $-42M | $-29M | $-36M | $-28M | $-19M | $-45M | $-27M | $-85M | $-82M | $-73M | $-50M | |
| Market Cap | $14M | · | $1.26B | $157M | · | · | $24.01B | $20.71B | $146.29B | $159.50B | $780.07B | $3.12T | |
| Enterprise Value | $6M | · | $1.23B | $136M | · | · | $23.95B | $20.64B | · | · | · | · | |
| P/E | -0.5 | -0.6 | -29.9 | -4.8 | -9.2 | -10.2 | · | · | · | · | · | · | |
| P/S | 54.6 | · | 4868.7 | 607.2 | · | · | 92693.9 | 79954.6 | 495914.6 | 244264.4 | 2816122.6 | · | |
| P/B | 2.1 | · | 47.1 | 8.7 | · | · | 410.1 | 291.9 | 2275.3 | 1473.9 | 6149.5 | 56307.1 | |
| P / Tangible Book | 2.1 | 25.0 | 47.1 | 8.7 | 13.1 | · | · | · | · | · | · | · | |
| P / Cash Flow | -0.5 | · | -46.1 | -5.1 | · | · | -582.4 | -875.7 | -3211.7 | -2583.7 | -15512.6 | -101843.6 | |
| P / FCF | -0.5 | · | -45.8 | -5.0 | · | · | -576.8 | -874.4 | -3200.6 | -2479.9 | -14051.4 | -93291.5 | |
| EV / EBITDA | -0.2 | · | -42.3 | -3.9 | · | · | -527.4 | -767.9 | · | · | · | · | |
| EV / FCF | -0.2 | · | -44.8 | -4.3 | · | · | -575.4 | -871.3 | · | · | · | · | |
| EV / Revenue | 24.8 | · | 4757.9 | 526.6 | · | · | 92454.1 | 79673.1 | · | · | · | · | |
| Earnings Yield | -220.6% | -179.6% | -3.3% | -20.7% | -10.9% | -9.8% | · | · | · | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SG&A Expense | $3M | $5M | $4M | $3M | $4M | $3M | $3M | $3M | $4M | $4M | $3M | $2M | $3M | $3M | $3M | $3M | |
| Operating Income | $-5M | $-28M | $-4M | $-4M | $-8M | $-11M | $-14M | $-11M | $-10M | $-8M | $-8M | $-7M | $-7M | $-8M | $-9M | $-9M | |
| Interest Expense | · | · | · | · | · | · | · | · | $372.0K | $368.0K | · | $373.0K | $355.0K | $344.0K | $432.0K | $389.0K | |
| Other Non-op | $6.0K | $23.0K | $55.0K | $86.0K | $142.0K | $237.0K | $353.0K | $324.0K | $384.0K | $438.0K | $403.0K | $179.0K | $244.0K | $289.0K | $263.0K | $213.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-5M | $-28M | $-4M | $-4M | $-8M | $-11M | $-14M | $-11M | $-10M | $-8M | $-7M | $-7M | $-8M | $-8M | $-9M | $-9M | |
| EPS (Basic) | $-0.34 | $-2.53 | $-0.31 | $-0.79 | $-2.07 | $-3.16 | $-4.04 | $-5.32 | $-5.52 | $-4.62 | $-0.34 | $-0.48 | $-0.54 | $-0.55 | $-0.46 | $-0.66 | |
| EPS (Diluted) | $-0.34 | $-2.53 | $-0.31 | $-0.79 | $-2.07 | $-3.16 | $-4.04 | $-5.32 | $-5.52 | $-4.62 | $-0.34 | $-0.48 | $-0.54 | $-0.55 | $-0.46 | $-0.66 | |
| Shares (Basic) | 15,223,972 | 10,931,593 | · | 4,440,111 | 3,802,956 | 3,437,671 | · | 1,985,133 | 1,734,335 | 1,710,323 | · | 14,121,805 | 14,102,211 | 13,763,173 | · | 13,635,927 | |
| Shares (Diluted) | 15,223,972 | 10,931,593 | · | 4,440,111 | 3,802,956 | 3,437,671 | · | 1,985,133 | 1,734,335 | 1,710,323 | · | 14,121,805 | 14,102,211 | 13,763,173 | · | 13,635,927 | |
| EBITDA | $-5M | $-28M | · | $-4M | $-8M | $-11M | · | $-11M | $-10M | $-8M | · | $-7M | $-7M | $-8M | · | $-9M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $779.0K | $2M | $8M | $8M | $14M | $22M | $30M | $22M | $31M | $32M | $39M | $11M | $18M | $23M | $31M | $43M | |
| Prepaid Expense | $918.0K | $641.0K | $562.0K | $590.0K | $823.0K | $922.0K | $1M | $1M | $424.0K | $1M | $1M | $1M | $931.0K | $1M | $1M | $2M | |
| Other Current Assets | $417.0K | $3.0K | $355.0K | $352.0K | $482.0K | $356.0K | $535.0K | $385.0K | $35.0K | $469.0K | $96.0K | $232.0K | $393.0K | $419.0K | $263.0K | $935.0K | |
| Current Assets | $2M | $2M | $8M | $8M | $15M | $22M | $31M | $24M | $32M | $33M | $40M | $12M | $19M | $25M | $33M | $60M | |
| PP&E (Net) | $486.0K | $545.0K | $605.0K | $681.0K | $748.0K | $817.0K | $886.0K | $932.0K | $1M | $920.0K | $840.0K | $921.0K | $1M | $1M | $1M | $919.0K | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | $1M | $1M | |
| Other Non-current Assets | $501.0K | $509.0K | $517.0K | $519.0K | $529.0K | $538.0K | $485.0K | $448.0K | $448.0K | $448.0K | $448.0K | $393.0K | $398.0K | $429.0K | $429.0K | $683.0K | |
| Total Assets | $10M | $11M | $17M | $17M | $24M | $32M | $41M | $34M | $42M | $44M | $52M | $24M | $31M | $37M | $46M | $63M | |
| Accounts Payable | $2M | $585.0K | $1M | $922.0K | $5M | $2M | $2M | $2M | $1M | $1M | $845.0K | $1M | $868.0K | $1M | $1M | $925.0K | |
| Accrued Liabilities | $715.0K | $1M | $937.0K | $1M | $1M | $5M | $3M | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | |
| Current Liabilities | $4M | $3M | $3M | $4M | $7M | $13M | $14M | $14M | $15M | $11M | $9M | $7M | $9M | $8M | $7M | $24M | |
| Capital Leases | $6M | $7M | $7M | $7M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $10M | $10M | $10M | $503.0K | |
| Total Liabilities | $11M | $10M | $10M | $11M | $15M | $21M | $22M | $22M | $25M | $24M | $25M | $25M | $26M | $26M | $28M | $36M | |
| Long-term Debt | · | · | · | · | · | $4M | · | $8M | $11M | $11M | $11M | $10M | $10M | $10M | · | $15M | |
| Total Debt | · | · | · | $0 | $0 | $4M | · | $9M | $11M | $11M | · | $11M | $10M | $10M | · | $15M | |
| Common Stock | $16.0K | $14.0K | $5.0K | $4.0K | $4.0K | $4.0K | $3.0K | $27.0K | $24.0K | $22.0K | $22.0K | $14.0K | $13.0K | $11.0K | $11.0K | $10.0K | |
| Paid-in Capital | $274M | $271M | $240M | $236M | $236M | $229M | $226M | $205M | $200M | $194M | $192M | $157M | $156M | $154M | $154M | $153M | |
| Retained Earnings | $-275M | $-270M | $-233M | $-229M | $-226M | $-218M | $-207M | $-193M | $-183M | $-173M | $-165M | $-158M | $-151M | $-143M | $-136M | $-127M | |
| Stockholders' Equity | $-1M | $822.0K | $7M | $6M | $10M | $11M | $19M | $11M | $17M | $21M | $27M | $-1M | $5M | $11M | $18M | $27M | |
| Liabilities + Equity | $10M | $11M | $17M | $17M | $24M | $32M | $41M | $34M | $42M | $44M | $52M | $24M | $31M | $37M | $46M | $63M | |
| Shares Outstanding | 15,979,411 | 14,344,034 | 4,927,161 | 4,440,161 | 4,437,855 | 3,519,602 | 3,382,432 | 26,565,886 | 24,475,799 | 22,217,265 | 22,045,255 | 14,323,405 | 12,583,833 | 10,561,700 | 10,518,539 | 10,517,099 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-3M | $-8M | $-4M | $-7M | $-8M | $-8M | $-10M | $-10M | $-6M | $-7M | $-6M | $-6M | $-6M | $-8M | $-6M | $-9M | |
| CapEx | $0 | $0 | $0 | $0 | $0 | $0 | $3.0K | $15.0K | $249.0K | $168.0K | $7.0K | $0 | $117.0K | $46.0K | $356.0K | $108.0K | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $-3.0K | $-15.0K | $-249.0K | $-168.0K | $-7.0K | $0 | $-117.0K | $-46.0K | $-356.0K | $-108.0K | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Issued | · | · | $1M | $0 | $4M | $1M | $20M | $4M | $5M | $253.0K | $34M | $21.0K | $1M | $44.0K | $12.0K | $351.0K | |
| Net Stock Activity | · | · | · | · | · | $1M | · | · | · | $253.0K | · | · | · | $44.0K | · | · | |
| Financing Cash Flow | $2M | $2M | $4M | $13.0K | $1M | $-721.0K | $18M | $2M | $5M | $450.0K | $34M | $21.0K | $1M | $44.0K | $-5M | $350.0K | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | · | · | $-6M | $-5M | $-8M | · | $-9M | |
| Free Cash Flow | · | $-8M | · | · | · | $-8M | · | · | · | $-7M | · | · | · | $-8M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -30.7% | -129.1% | · | -13.8% | -23.6% | -28.4% | · | -36.5% | -26.2% | -19.4% | · | -15.6% | -14.8% | -14.6% | · | -13.7% | |
| ROE | -120.6% | -463.3% | · | -39.4% | -58.9% | -68.4% | · | -205.6% | -87.2% | -50.0% | · | -53.0% | -38.0% | -37.9% | · | -25.4% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.4 | 0.7 | · | 2.3 | 2.1 | 1.7 | · | 1.7 | 2.2 | 3.1 | · | 1.7 | 2.1 | 3.3 | · | 2.5 | |
| Quick Ratio | 0.2 | 0.5 | · | 2.1 | 2.0 | 1.6 | · | 1.6 | 2.1 | 3.0 | · | 1.5 | 2.0 | 3.1 | · | 1.8 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.4 | · | 0.7 | 0.6 | 0.5 | · | -8.8 | 2.1 | 0.9 | · | 0.6 | |
| LT Debt / Equity | · | · | · | · | · | · | · | 0.0 | 0.1 | 0.2 | · | -7.0 | 1.5 | 0.8 | · | 0.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -25.8 | -21.7 | · | -17.7 | -21.0 | -22.0 | · | -22.5 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.07 | $0.06 | · | $1.43 | $2.20 | $3.16 | · | $0.43 | $0.69 | $0.93 | · | $-0.08 | $0.40 | $1.04 | · | $2.55 | |
| Cash Flow / Share | · | $-0.69 | · | · | · | $-2.34 | · | · | · | $-0.32 | · | · | · | $-0.60 | · | · | |
| Cash / Share | $0.05 | $0.13 | · | $1.69 | $3.22 | $6.11 | · | $0.83 | $1.27 | $1.46 | · | $0.78 | $1.40 | $2.17 | · | $4.07 | |
| EPS (TTM) | $-3.97 | $-5.70 | · | $-10.06 | $-14.59 | $-18.04 | · | $-15.80 | $-10.96 | $-5.98 | · | $-2.03 | $-2.21 | $-2.46 | · | $9.29 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-40M | $-43M | · | $-36M | $-43M | $-45M | · | $-36M | $-32M | $-30M | · | $-31M | $-33M | $-35M | · | $-34M | |
| Market Cap | $18M | $24M | · | $46M | $30M | $34M | · | $483M | $697M | $1.13B | · | $57M | $208M | $319M | · | $238M | |
| Enterprise Value | · | · | · | $38M | $16M | $16M | · | $470M | $676M | $1.11B | · | $56M | $201M | $306M | · | $210M | |
| P/E | -0.3 | -0.3 | · | -1.0 | -0.5 | -0.5 | · | -1.2 | -2.6 | -8.5 | · | -2.0 | -7.5 | -12.3 | · | 2.4 | |
| P/B | -16.3 | 28.6 | · | 7.2 | 3.1 | 3.0 | · | 42.2 | 41.1 | 54.7 | · | -47.7 | 41.5 | 29.1 | · | 8.9 | |
| P / Tangible Book | · | 28.6 | · | 7.2 | 3.1 | 3.0 | · | 42.2 | 41.1 | 54.7 | · | · | 41.5 | 29.1 | · | 8.9 | |
| P / Cash Flow | · | -3.1 | · | · | · | -4.2 | · | · | · | -157.2 | · | · | · | -38.4 | · | · | |
| Earnings Yield | -357.7% | -347.6% | · | -97.9% | -214.6% | -188.0% | · | -86.8% | -38.5% | -11.8% | · | -51.2% | -13.4% | -8.2% | · | 41.1% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Gelir | $-26M | $-42M | $-29M | $-36M | $-28M |
| Seyreltilmiş Hisse Başı Kâr | $-6.33 | $-19.50 | $-1.91 | $-3.09 | $-7.47 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.0 | · | 0.4 | 0.6 | · |
| Cari Oran | 2.5 | · | 4.3 | 4.5 | · |
| Cari Oran | 2.3 | · | 4.2 | 4.3 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-27M | · | $-28M | $-32M | · |
Kurumsal Sahipler (13F) 23 dosya · $1.9M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
23
Tutulan Değer
$1.9M
Yeni pozisyonlar
4
Çıkan pozisyonlar
5
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 4 (-1 önceki Ç'ye göre) | 5 (+4 önceki Ç'ye göre) | 5 (+2 önceki Ç'ye göre) | 3 (0 önceki Ç'ye göre) | +507K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| SABBY MANAGEMENT, LLC | $567.527 | 511.286 | 29,75% | Hisse senetleri |
| VANGUARD GROUP INC | $466.547 | 162.560 | 24,45% | Hisse senetleri |
| Versant Venture Management, LLC | $299.447 | 269.772 | 15,69% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $259.616 | 233.888 | 13,61% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $96.155 | 86.625 | 5,04% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $76.488 | 68.908 | 4,01% | Hisse senetleri |
| BlackRock, Inc. | $43.365 | 39.068 | 2,27% | Hisse senetleri |
| Squarepoint Ops LLC | $34.299 | 30.900 | 1,80% | Hisse senetleri |
| NORTHERN TRUST CORP | $22.351 | 20.136 | 1,17% | Hisse senetleri |
| CITADEL ADVISORS LLC | $22.000 | 19.820 | 1,15% | Hisse senetleri |
| UBS Group AG | $6.255 | 5.636 | 0,33% | Hisse senetleri |
| CIBC Private Wealth Group LLC | $4.729 | 460 | 0,25% | Hisse senetleri |
| Tower Research Capital LLC (TRC) | $4.353 | 3.922 | 0,23% | Hisse senetleri |
| MORGAN STANLEY | $2.244 | 2.022 | 0,12% | Hisse senetleri |
| OSAIC HOLDINGS, INC. | $1.669 | 1.513 | 0,09% | Hisse senetleri |
| Federation des caisses Desjardins du Quebec | $324 | 292 | 0,02% | Hisse senetleri |
| JONES FINANCIAL COMPANIES LLLP | $258 | 239 | 0,01% | Hisse senetleri |
| BARCLAYS PLC | $246 | 222 | 0,01% | Hisse senetleri |
| SBI Securities Co., Ltd. | $62 | 56 | 0,00% | Hisse senetleri |
| Parallel Advisors, LLC | $20 | 18 | 0,00% | Hisse senetleri |
| Caitong International Asset Management Co., Ltd | $3 | 3 | 0,00% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $3 | 3 | 0,00% | Hisse senetleri |
| ROYAL BANK OF CANADA | $0 | 28 | 0,00% | Hisse senetleri |
Aktivistler ve %5+ sahipler 11 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage II, L.P., Versant Vantage II GP, L.P., Versant Vantage II GP-GP, LLC, Versant Venture Capital IV, L.P., Versant Side Fund IV, L.P., Versant Ventures IV, LLC ×8 başvurular | 02 Nisan 2026 | 1,10% | Değişiklik | · | SEC |
| Matthew Angel ×2 başvurular | 25 Mart 2026 | 37,40% | Değişiklik | · | SEC |
| New Enterprise Associates 15, L.P., NEA Partners 15, L.P., NEA 15 GP, LLC, Forest Baskett, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Peter W. Sonsini ×2 başvurular | 13 Nisan 2021 | · | İlk başvuru | · | SEC |
| Fonds Innobio FPCI, Bpifrance Investissement S.A.S., Bpifrance Participations S.A., Caisse des Dépôts, EPIC Bpifrance, Bpifrance S.A. ×3 başvurular | 30 Temmuz 2020 | · | İlk başvuru | Pasif yatırım | SEC |
| BML Investment Partners, L.P., Braden M Leonard (1) | 14 Eylül 2018 | · | İlk başvuru | M&A / satış | SEC |
| Michelle Dipp, M.D., Ph.D. (2) ×5 başvurular | 03 Mayıs 2018 | · | İlk başvuru | · | SEC |
| Richard Aldrich (2) ×4 başvurular | 03 Haziran 2016 | · | İlk başvuru | · | SEC |
| Longwood Fund, L.P. (2), Longwood Fund GP, LLC (2), Christoph Westphal, M.D., Ph.D. (2), Richard Aldrich (2), Michelle Dipp, M.D., Ph.D. (2) ×6 başvurular | 20 Mart 2015 | · | İlk başvuru | · | SEC |
| DEER VII & CO. LTD., DEER VII & CO. L.P., BESSEMER VENTURE PARTNERS VII L.P., BESSEMER VENTURE PARTNERS VII INSTITUTIONAL L.P., BVP VII SPECIAL OPPORTUNITY FUND L.P., DEER MANAGEMENT CO. LLC ×6 başvurular | 16 Ocak 2015 | · | İlk başvuru | · | SEC |
| 31 Temmuz 2013 | · | İlk başvuru | · | SEC | |
| General Catalyst Group V, L.P., GC Entrepreneurs Fund V, L.P., General Catalyst Partners V, L.P., General Catalyst GP V, LLC, Joel E. Cutler, David P. Fialkow, David J. Orfao ×2 başvurular | 21 Mart 2013 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 57 içeriden öğrenenler · 28 yöneticiler · 33 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Matthew Angel | CEO and President | 24 Mart 2026 P | 231.482 | 2 | 0 | $1.000.002 |
| Stephen R Brady | President and CEO | 02 Ocak 2025 A | 46.376 | 0 | 0 | $0 |
| Iii Louis J Arcudi | President and CEO | 26 Şubat 2021 A | · | 0 | 0 | $0 |
| Christopher A. Kroeger | Chief Executive Officer | 10 Mayıs 2018 A | · | 0 | 0 | $0 |
| Nicholas Maestas | Chief Financial Officer | 31 Mart 2026 A | · | 0 | 0 | $0 |
| Jennifer Lynn Minai-Azary | Chief Financial Officer | 26 Şubat 2021 A | · | 0 | 0 | $0 |
| Christophe Couturier | Chief Financial Officer | 23 Aralık 2016 A | 50.900 | 0 | 0 | $0 |
| Jeffrey E Young | Chief Financial Officer | 03 Aralık 2015 A | 53.750 | 0 | 0 | $0 |
| Thomas W. Dubensky | President | 03 Ocak 2023 A | 113.343 | 0 | 0 | $0 |
| Arthur Tzianabos | President and CSO | 03 Aralık 2015 A | 25.400 | 0 | 0 | $0 |
| Paul W.D. Chapman | Chief Operating Officer | 10 Mayıs 2016 P | 3.100 | 0 | 0 | $0 |
| Alison Frances Lawton | Chief Operating Officer | 07 Haziran 2013 A | · | 0 | 0 | $0 |
| Justin Trojanowski | Corporate Controller | 31 Mart 2026 A | 22.168 | 0 | 0 | $0 |
| Samuel Whiting | Chief Medical Officer | 02 Ocak 2025 A | 9.573 | 0 | 0 | $0 |
| Pierre Lorenzo | Corporate Controller | 21 Haziran 2022 A | 53 | 0 | 0 | $0 |
| Julia C. Owens | Executive Chair | 17 Mart 2021 A | 74.400 | 0 | 0 | $0 |
| Christophe Arbet-Engels | Chief Medical Officer | 25 Mayıs 2020 A | · | 0 | 0 | $0 |
| Ryan Zeidan | Chief Development Officer | 25 Mayıs 2020 A | · | 0 | 0 | $0 |
| Tamara L Joseph | General Counsel and Secretary | 25 Mayıs 2020 A | · | 0 | 0 | $0 |
| Pharis Mohideen | Chief Medical Officer | 15 Ocak 2019 A | 7.440 | 0 | 0 | $0 |
| Jeffery M. Brinza | Sec., CAO and General Counsel | 15 Ocak 2019 A | · | 0 | 0 | $0 |
| James Woodruff Lillie | Chief Scientific Officer | 10 Mayıs 2018 A | · | 0 | 0 | $0 |
| Jonathan Gillis | Senior Vice President, Finance | 10 Mayıs 2018 A | · | 0 | 0 | $0 |
| Michelle Dipp | Executive Chair | 21 Haziran 2017 A | 962.056 | 0 | 0 | $0 |
| Theresa Mcneely | EVP, Chief Comm. Officer | 09 Nisan 2015 P | 400 | 0 | 0 | $0 |
| David Harding | Chief Commercial Officer | 10 Nisan 2014 P | 2.290 | 0 | 0 | $0 |
| Christopher A Bleck | Chief Commercial Officer | 11 Eylül 2013 P | 2.000 | 0 | 0 | $0 |
| Christopher M Lindblom | Vice President of Finance | 07 Haziran 2013 A | · | 0 | 0 | $0 |
| Nancy Freda Smith | Yönetim kurulu üyesi | 22 Eylül 2026 A | · | 0 | 0 | $0 |
| William Drake Richey | Yönetim kurulu üyesi | 04 Haziran 2026 A | · | 0 | 0 | $0 |
| John D. Yee | Yönetim kurulu üyesi | 04 Haziran 2026 A | · | 0 | 0 | $0 |
| Ronit Simantov | Yönetim kurulu üyesi | 27 Ocak 2026 A | · | 0 | 0 | $0 |
| Geoffrey Nichol | Yönetim kurulu üyesi | 27 Ocak 2026 A | · | 0 | 0 | $0 |
| Christine A Pellizzari | Yönetim kurulu üyesi | 27 Ocak 2026 A | · | 0 | 0 | $0 |
| Thomas Woiwode | Yönetim kurulu üyesi | 17 Haziran 2022 A | 2.118.644 | 0 | 0 | $0 |
| Stella Xu | Yönetim kurulu üyesi | 01 Temmuz 2021 A | 579.710 | 0 | 0 | $0 |
| Habib J Dable | Yönetim kurulu üyesi | 22 Haziran 2020 A | · | 0 | 0 | $0 |
| Carole Nuechterlein | Yönetim kurulu üyesi | 22 Haziran 2020 A | · | 0 | 0 | $0 |
| James M. Hindman | Yönetim kurulu üyesi | 22 Haziran 2020 A | · | 0 | 0 | $0 |
| Mary Lynne Hedley | Yönetim kurulu üyesi | 22 Haziran 2020 A | · | 0 | 0 | $0 |
| Carol Giltner Gallagher | Yönetim kurulu üyesi | 22 Haziran 2020 A | 23.684 | 0 | 0 | $0 |
| John P Howe MD | Yönetim kurulu üyesi | 22 Haziran 2020 A | · | 0 | 0 | $0 |
| Randall W Whitcomb | Yönetim kurulu üyesi | 20 Haziran 2019 A | 15.784 | 0 | 0 | $0 |
| Mary Fisher | Yönetim kurulu üyesi | 07 Aralık 2018 A | 3.319 | 0 | 0 | $0 |
| Marc D Kozin | Yönetim kurulu üyesi | 07 Aralık 2018 A | 7.740 | 0 | 0 | $0 |
| Richard Aldrich | Yönetim kurulu üyesi | 07 Aralık 2018 A | 6.169 | 0 | 0 | $0 |
| John Sexton | Yönetim kurulu üyesi | 04 Temmuz 2018 A | · | 0 | 0 | $0 |
| Jeffrey D Capello | Yönetim kurulu üyesi | 04 Temmuz 2018 A | 11.111 | 0 | 0 | $0 |
| Thomas Malley | Yönetim kurulu üyesi | 13 Haziran 2017 A | 204.981 | 0 | 0 | $0 |
| Harald F. Stock | Yönetim kurulu üyesi | 05 Ocak 2016 A | 251.228 | 0 | 0 | $0 |
| Deer Management Co. LLC | Yönetim kurulu üyesi | 13 Haziran 2014 A | · | 0 | 0 | $0 |
| Stephen Kraus | Yönetim kurulu üyesi | 13 Haziran 2014 A | 0 | 0 | 0 | $0 |
| Christoph H Westphal | Yönetim kurulu üyesi | 07 Mart 2014 P | 3.820.571 | 0 | 0 | $0 |
| Jonathan L Tilly | Yönetim kurulu üyesi | 07 Haziran 2013 A | · | 0 | 0 | $0 |
| John G Simon | Yönetim kurulu üyesi | 13 Ağustos 2012 C | 1.090.908 | 0 | 0 | $0 |
| Longwood Fund, L.P. | 10% sahip | 14 Ocak 2015 J | 319.082 | 0 | 0 | $0 |
| Michael Raab | · | 27 Ocak 2026 A | · | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 2 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
TPST Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 7 analist
AL
Medyan hedef
$7.00
+762,9%
2 28,6%
Güçlü Al
4 57,1%
Al
1 14,3%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
1 analist · 2026-09-29Ortalama hedef $7.00 +762,9%
Düşük$7.00
Ortalama$7.00
Yüksek$7.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 13, 2026